Mutations in the region corresponding to the N-terminal phosphorylation sites (codons 1-51) of the rat
beta-catenin gene (Ctnnb1) were investigated in rat colon
tumors induced by
1-hydroxyanthraquinone (1-HA) plus
methylazoxymethanol (MAM)
acetate, by using polymerase chain reaction (PCR)-single-strand conformation polymorphism (SSCP) analysis. The
beta-catenin gene was also screened for mutations in rat brain and oral
tumors induced by ethyl nitrosourea (ENU) and 4-nitroquinoline 1-oxide (4-NQO), respectively. In colon
tumors,
beta-catenin gene mutations were found in two of three
adenomas (67%) and 26 of 28
adenocarcinomas (93%), with a total incidence of 90% (28 of 31
adenomas plus
adenocarcinomas). Eight (29%) were (34)G-->T (second position), eight (29%) were (32)G-->A (first position), five (18%) were (34)G-->A (first position), five (18%) were (41)C-->T (second position), one (4%) was (34)G-->A (second position), and one (4%) was (32)A-->G (second position), mutations, resulting in the substitutions of Gly(34)-->Val, Asp(32)-->Asn, Gly(34)-->Arg, Thr(41)-->Ile, Gly(34)-->Glu, and Asp(32)-->Gly, respectively. The (34)G-->T (second position) mutations found in this study were unique compared to those found in other
carcinogen-induced rat colon
carcinogenesis models. In contrast,
beta-catenin gene mutations were not found in either the brain or oral
tumors. These results suggest that mutations in the
beta-catenin gene in rat
tumors occur in specific tissues or organ sites and in a
carcinogen-specific manner. Thus, the mutation spectrum in the
beta-catenin gene is organ- and chemical
carcinogen-specific.